Jaysynth Orgochem Ltd is Rated Sell

2 hours ago
share
Share Via
Jaysynth Orgochem Ltd is rated Sell by MarketsMojo, with this rating last updated on 05 August 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 02 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Jaysynth Orgochem Ltd is Rated Sell

Rating Context and Current Position

The rating for Jaysynth Orgochem Ltd was revised to Sell on 05 August 2025, reflecting a significant change in the company’s overall assessment. The Mojo Score dropped by 20 points, from 51 to 31, signalling a more cautious stance towards the stock. It is important to note that while the rating change occurred several months ago, the data and analysis below are based on the latest available information as of 02 March 2026, ensuring investors understand the stock’s present-day fundamentals and market behaviour.

Quality Assessment

Currently, Jaysynth Orgochem Ltd holds an average quality grade. This indicates that while the company maintains a stable operational framework, it does not exhibit strong competitive advantages or exceptional management efficiency that would typically characterise higher-quality stocks. The average quality rating suggests moderate business risks and a need for investors to carefully monitor operational developments and sector dynamics.

Valuation Perspective

From a valuation standpoint, the stock is considered very attractive as of 02 March 2026. This implies that the market price is relatively low compared to the company’s earnings, assets, or cash flow, potentially offering value opportunities for investors willing to accept the associated risks. Despite the appealing valuation, it is crucial to weigh this against other factors such as financial health and market trends before making investment decisions.

Financial Trend Analysis

The financial grade for Jaysynth Orgochem Ltd is currently negative, reflecting deteriorating financial performance. The latest quarterly results show a decline in profitability, with profit before tax excluding other income falling by 36.9% to ₹2.78 crores, and profit after tax dropping by 38.6% to ₹2.33 crores compared to the previous four-quarter average. Additionally, the operating profit to net sales ratio has reached a low of 5.96%, signalling margin pressures. These trends highlight challenges in sustaining earnings growth and operational efficiency.

Technical Outlook

The technical grade is bearish, indicating that the stock’s price momentum and chart patterns are currently unfavourable. Over various time frames, the stock has underperformed significantly. As of 02 March 2026, Jaysynth Orgochem Ltd has delivered negative returns of -1.29% in one day, -2.00% over one week, -9.79% in one month, and a steep -42.33% over the past year. This contrasts sharply with the broader BSE500 index, which has generated positive returns of 14.54% over the same one-year period. The bearish technical signals suggest continued downward pressure on the stock price in the near term.

Stock Performance and Market Comparison

Jaysynth Orgochem Ltd’s performance has lagged behind the market considerably. The stock’s one-year return of -42.33% starkly contrasts with the BSE500’s positive 14.54% return, underscoring the company’s underperformance within the broader market context. The negative trend extends across shorter time frames as well, with losses accumulating steadily over the past six months (-38.85%) and year-to-date (-17.50%). This persistent underperformance is a key factor influencing the current Sell rating.

Operational Challenges Evident in Latest Results

The December 2025 quarterly results reveal operational headwinds. Profit before tax excluding other income declined sharply by 36.9%, while profit after tax decreased by 38.6% compared to the previous four-quarter average. The operating profit margin has also contracted to its lowest level at 5.96%, indicating margin compression and potential cost pressures. These financial setbacks contribute to the negative financial grade and reinforce the cautious stance on the stock.

Only 1% make it here. This Large Cap from the Gems, Jewellery And Watches sector passed our rigorous filters with flying colors. Be among the first few to spot this gem!

  • - Highest rated stock selection
  • - Multi-parameter screening cleared
  • - Large Cap quality pick

View Our Top 1% Pick →

What the Sell Rating Means for Investors

The Sell rating assigned to Jaysynth Orgochem Ltd by MarketsMOJO reflects a cautious outlook based on a combination of average quality, very attractive valuation, negative financial trends, and bearish technical indicators. For investors, this rating suggests that the stock currently carries elevated risks that may outweigh potential rewards. The attractive valuation could entice value-focused investors, but the deteriorating profitability and weak price momentum warrant careful consideration.

Investors should interpret this Sell rating as a signal to either avoid initiating new positions or consider reducing existing exposure, especially if risk tolerance is low. The rating also emphasises the importance of monitoring quarterly results and market developments closely, as any improvement in financial health or technical outlook could alter the stock’s prospects.

Sector and Market Context

Operating within the Specialty Chemicals sector, Jaysynth Orgochem Ltd faces sector-specific challenges including raw material cost volatility and competitive pressures. The microcap status of the company adds an additional layer of risk due to lower liquidity and higher price volatility compared to larger peers. Against the backdrop of a generally positive market environment, as evidenced by the BSE500’s gains, the stock’s underperformance highlights company-specific issues rather than broad sector weakness.

Summary

In summary, Jaysynth Orgochem Ltd’s current Sell rating is justified by a combination of average operational quality, very attractive valuation, negative financial trends, and bearish technical signals. The stock’s significant underperformance relative to the broader market and recent quarterly results showing declining profitability reinforce this cautious stance. Investors should carefully weigh these factors when considering their portfolio allocation and remain vigilant for any changes in the company’s fundamentals or market conditions.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News